Journal of Psychosomatic Research
Volume 62, Issue 1 , Pages 85-91 , January 2007

The low-dose dexamethasone suppression test in fibromyalgia

  • Katja Wingenfeld

      Affiliations

    • Department of Psychobiology, University of Trier, Trier, Germany
    • Department of Psychiatry and Psychotherapy Bethel, Bielefeld, Germany
    • ,
  • Dieter Wagner

      Affiliations

    • Department of Psychobiology, University of Trier, Trier, Germany
    • ,
  • Iris Schmidt

      Affiliations

    • Department of Psychobiology, University of Trier, Trier, Germany
    • ,
  • Gunther Meinlschmidt

      Affiliations

    • Department of Psychobiology, University of Trier, Trier, Germany
    • Institute of Psychology, University of Basel, Basel, Switzerland
    • ,
  • Dirk H. Hellhammer

      Affiliations

    • Department of Psychobiology, University of Trier, Trier, Germany
    • ,
  • Christine Heim

      Affiliations

    • Department of Psychobiology, University of Trier, Trier, Germany
    • Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA
    • Corresponding Author InformationCorresponding author. Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 101 Woodruff Circle, WMRB, Suite 4311, Atlanta, GA 30322, USA. Tel.: +1 404 727 5835; fax: +1 404 727 3233

Received 4 October 2005 ,Revised 24 April 2006 ,Accepted 27 June 2006.

References 

  1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160–172
  2. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38:19–28
  3. Wolfe F. Fibromyalgia: the clinical syndrome. Rheum Dis Clin North Am. 1989;15:1–18
  4. Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology. 2000;25:1–35
  5. Crofford LJ, Pillemer SR, Kalogeras KT, Cash JM, Michelson D, Kling MA, et al. Hypothalamic–pituitary–adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum. 1994;37:1583–1592
  6. McCain GA, Tilbe KS. Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. J Rheumatol Suppl. 1989;19:154–157
  7. Griep EN, Boersma JW, Lentjes EG, Prins AP, van der Korst JK, de Kloet ER. Function of the hypothalamic–pituitary–adrenal axis in patients with fibromyalgia and low back pain. J Rheumatol. 1998;25:1374–1381
  8. Griep EN, Boersma JW, de Kloet ER. Altered reactivity of the hypothalamic–pituitary–adrenal axis in the primary fibromyalgia syndrome. J Rheumatol. 1993;20:469–474
  9. Riedel W, Layka H, Neeck G. Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones. Z Rheumatol. 1998;57(Suppl 2):81–87
  10. Calis M, Gokce C, Ates F, Ulker S, Izgi HB, Demir H, et al. Investigation of the hypothalamo–pituitary–adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome. J Endocrinol Invest. 2004;27:42–46
  11. Kirnap M, Colak R, Eser C, Ozsoy O, Tutus A, Kelestimur F. A comparison between low-dose (1 microg), standard-dose (250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo–pituitary–adrenal axis in primary fibromyalgia syndrome. Clin Endocrinol (Oxf). 2001;55:455–459
  12. Carroll BJ. The dexamethasone suppression test for melancholia. Br J Psychiatry. 1982;140:292–304
  13. Ferraccioli G, Cavalieri F, Salaffi F, Fontana S, Scita F, Nolli M, et al. Neuroendocrinologic findings in primary fibromyalgia (soft tissue chronic pain syndrome) and in other chronic rheumatic conditions (rheumatoid arthritis, low back pain). J Rheumatol. 1990;17:869–873
  14. Ataoglu S, Ozcetin A, Yildiz O, Ataoglu A. Evaluation of dexamethasone suppression test in fibromyalgia patients with or without depression. Swiss Med Wkly. 2003;133:241–244
  15. Yehuda R, Giller EL, Southwick SM, Lowy MT, Mason JW. Hypothalamic–pituitary–adrenal dysfunction in posttraumatic stress disorder. Biol Psychiatry. 1991;30:1031–1048
  16. Yehuda R, Southwick SM, Krystal JH, Bremner D, Charney DS, Mason JW. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am J Psychiatry. 1993;150:83–86
  17. Yehuda R, Boisoneau D, Lowy MT, Giller EL. Dose–response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch Gen Psychiatry. 1995;52:583–593
  18. Yehuda R, Halligan SL, Grossman R, Golier JA, Wong C. The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and holocaust survivors with and without posttraumatic stress disorder. Biol Psychiatry. 2002;52:393–403
  19. Yehuda R, Golier JA, Halligan SL, Meaney M, Bierer LM. The ACTH response to dexamethasone in PTSD. Am J Psychiatry. 2004;161:1397–1403
  20. Gaab J, Huster D, Peisen R, Engert V, Schad T, Schurmeyer TH, et al. Low-dose dexamethasone suppression test in chronic fatigue syndrome and health. Psychosom Med. 2002;64:311–318
  21. Heim C, Ehlert U, Hanker JP, Hellhammer DH. Abuse-related posttraumatic stress disorder and alterations of the hypothalamic–pituitary–adrenal axis in women with chronic pelvic pain. Psychosom Med. 1998;60:309–318
  22. Wittchen HU, Zaudig M, Fydrich T. Strukturiertes Klinisches Interview für DSM-IV. Achse I: Psychische Störungen. SKID-I. Goettingen: Hogrefe; 1997;
  23. Zung WW. Depression status inventory and self-rating depression scale. In: Collegium Internationale Psychiatriae Scalarum (CIPS)  editors. Internationale Skalen für Psychiatrie. Weinheim: Beltz; 1986;
  24. Laux L, Glanzmann P, Schaffner P, Spielberger CD. Das State–Trait-Angstinventar. Theoretischen Grundlagen und Hansanweisung. Weinheim: Beltz; 1981;
  25. Ehlers A, Steil R, Foa EB. Deutsche Übersetzung der Posttraumatic Stress Diagnostic Scale (PDS). Oxford: University, Warneford Hospital, Department of Psychiatry; 1996;
  26. Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al. Development of a fatigue scale. J Psychosom Res. 1993;37:147–153
  27. Fahrenberg J. Die Freiburger Beschwerdeliste (FBL). Goettingen: Hogrefe; 1994;
  28. Bremner JD, Vermetten E, Mazure CM. Development and preliminary psychometric properties of an instrument for the measurement of childhood trauma: the Early Trauma Inventory. Depress Anxiety. 2000;12:1–12
  29. Resnick HS, Kilpatrick DG, Dansky BS, Saunders BE, Best CL. Prevalence of civilian trauma and posttraumatic stress disorder in a representative national sample of women. J Consult Clin Psychol. 1993;61:984–991
  30. Kanner AD, Coyne JC, Schaefer C, Lazarus RS. Comparison of two modes of stress measurement: daily hassles and uplifts versus major life events. J Behav Med. 1981;4:1–39
  31. Sarason IG, Johnson JH, Siegel JM. Assessing the impact of life changes: development of the Life Experiences Survey. J Consult Clin Psychol. 1978;46:932–946
  32. Schulz P, Schlotz W. Trierer Inventar zur Erfassung von chronischem Stress (TICS). Skalenkonstruktion, teststatistische Überprüfung und Validierung der Skala Arbeitsüberlastung. Diagnostika. 1999;45:8–19
  33. Schulz P, Jansen LJ, Schlotz W. Stressreaktivität: theoretisches konzept und messung. Diagnostica. 2005;51:124–133
  34. Sapolsky RM. Glucocorticoids, stress, and their adverse neurological effects: relevance to aging. Exp Gerontol. 1999;34:721–732
  35. Giordano R, Bo M, Pellegrino M, Vezzari M, Baldi M, Picu A, et al. Hypothalamus–pituitary–adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade. J Clin Endocrinol Metab. 2005;90:5656–5662
  36. Rosmond R. Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology. 2005;30:1–10
  37. Lindheim SR, Legro RS, Bernstein L, Stanczyk FZ, Vijod MA, Presser SC, et al. Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen. Am J Obstet Gynecol. 1992;167:1831–1836
  38. Kudielka BM, Schmidt-Reinwald AK, Hellhammer DH, Kirschbaum C. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment. Neuroendocrinology. 1999;70:422–430
  39. Kudielka BM, Kirschbaum C. Sex differences in HPA axis responses to stress: a review. Biol Psychol. 2005;69:113–132
  40. Cassidy F, Ritchie JC, Verghese K, Carroll BJ. Dexamethasone metabolism in dexamethasone suppression test suppressors and nonsuppressors. Biol Psychiatry. 2000;47:677–680
  41. Stokes PE, Sikes C, Lasley B, Stoll P. HPA hyperactivity with increased plasma cortisol affects dexamethasone metabolism and DST outcome. J Psychiatr Res. 2002;36:417–421
  42. Yehuda R. Current status of cortisol findings in post-traumatic stress disorder. Psychiatr Clin North Am. 2002;25:341–368
  43. Newport DJ, Heim C, Bonsall R, Miller AH, Nemeroff CB. Pituitary–adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse. Biol Psychiatry. 2004;55:10–20
  44. Loose DS, Do YS, Chen TL, Feldman D. Demonstration of glucocorticoid receptors in the adrenal cortex: evidence for a direct dexamethasone suppressive effect on the rat adrenal gland. Endocrinology. 1980;107:137–146
  45. Kontula K, Pomoell UM, Gunsalus GL, Pelkonen R. Glucocorticoid receptors and responsiveness of normal and neoplastic human adrenal cortex. J Clin Endocrinol Metab. 1985;60:283–289
  46. Engel CC, Walker EA, Engel AL, Bullis J, Armstrong A. A randomized, double-blind crossover trial of sertraline in women with chronic pelvic pain. J Psychosom Res. 1998;44:203–207
  47. Bornstein SR, Chrousos GP. Clinical review 104: adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. J Clin Endocrinol Metab. 1999;84:1729–1736
  48. Whitworth EJ, Kosti O, Renshaw D, Hinson JP. Adrenal neuropeptides: regulation and interaction with ACTH and other adrenal regulators. Microsc Res Tech. 2003;61:259–267
  49. Aaron LA, Bradley LA, Alarcon GS, Alexander RW, Triana-Alexander M, Martin MY, et al. Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum. 1996;39:436–445
  50. Amir M, Kaplan Z, Neumann L, Sharabani R, Shani N, Buskila D. Posttraumatic stress disorder, tenderness and fibromyalgia. J Psychosom Res. 1997;42:607–613
  51. Walker EA, Keegan D, Gardner G, Sullivan M, Katon WJ, Bernstein D. Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: I. Psychiatric diagnoses and functional disability. Psychosom Med. 1997;59:565–571
  52. Epstein SA, Kay G, Clauw D, Heaton R, Klein D, Krupp L, et al. Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics. 1999;40:57–63
  53. Roy-Byrne P, Smith WR, Goldberg J, Afari N, Buchwald D. Post-traumatic stress disorder among patients with chronic pain and chronic fatigue. Psychol Med. 2004;34:363–368
  54. Hudson JI, Goldenberg DL, Pope HG, Keck PE, Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med. 1992;92:363–367
  55. Elzinga BM, Schmahl CG, Vermetten E, van Dyck R, Bremner JD. Higher cortisol levels following exposure to traumatic reminders in abuse-related PTSD. Neuropsychopharmacology. 2003;28:1656–1665
  56. Heim C, Newport DJ, Heit S, Graham YP, Wilcox M, Bonsall R, et al. Pituitary–adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA. 2000;284:592–597
  57. Heim C, Newport DJ, Bonsall R, Miller AH, Nemeroff CB. Altered pituitary–adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry. 2001;158:575–581
  58. Boisset-Pioro MH, Esdaile JM, Fitzcharles MA. Sexual and physical abuse in women with fibromyalgia syndrome. Arthritis Rheum. 1995;38:235–241
  59. Taylor ML, Trotter DR, Csuka ME. The prevalence of sexual abuse in women with fibromyalgia. Arthritis Rheum. 1995;38:229–234
  60. Walker EA, Keegan D, Gardner G, Sullivan M, Bernstein D, Katon WJ. Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: II. Sexual, physical, and emotional abuse and neglect. Psychosom Med. 1997;59:572–577
  61. Imbierowicz K, Egle UT. Childhood adversities in patients with fibromyalgia and somatoform pain disorder. Eur J Pain. 2003;7:113–119
  62. Dailey PA, Bishop GD, Russell IJ, Fletcher EM. Psychological stress and the fibrositis/fibromyalgia syndrome. J Rheumatol. 1990;17:1380–1385
  63. Uveges JM, Parker JC, Smarr KL, McGowan JF, Lyon MG, Irvin WS, et al. Psychological symptoms in primary fibromyalgia syndrome: relationship to pain, life stress, and sleep disturbance. Arthritis Rheum. 1990;33:1279–1283
  64. McLean SA, Williams DA, Harris RE, Kop WJ, Groner KH, Ambrose K, et al. Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis Rheum. 2005;52:3660–3669
  65. Weissbecker I, Floyd A, Dedert E, Salmon P, Sephton S. Childhood trauma and diurnal cortisol disruption in fibromyalgia syndrome. Psychoneuroendocrinology. 2006;31:312–324
  66. Alexander RW, Bradley LA, Alarcon GS, Triana-Alexander M, Aaron LA, Alberts KR, et al. Sexual and physical abuse in women with fibromyalgia: association with outpatient health care utilization and pain medication usage. Arthritis Care Res. 1998;11:102–115

PII: S0022-3999(06)00329-1

doi: 10.1016/j.jpsychores.2006.06.006

Journal of Psychosomatic Research
Volume 62, Issue 1 , Pages 85-91 , January 2007

Article Tools